Selecting the target and the message for a stroke public education campaign:: A local survey conducted by neurologists

被引:42
作者
Montaner, J [1 ]
Vidal, C [1 ]
Molina, C [1 ]
Alvarez-Sabín, J [1 ]
机构
[1] Hosp Gen Valle Hebron, Serv Neurol, Cerebrovasc Unit, Barcelona 08035, Spain
关键词
health education; risk factors knowledge; stroke; TIA; warning signs;
D O I
10.1023/A:1014581003849
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
In order to determine the baseline knowledge of stroke among population (terminology, signs and symptoms, risk factors (RF) and attitude) to select the best target and message, prior to educational campaigns, a structured interview using close-ended questions was conducted by neurologists among 1000 users of several Primary Health Centers around our Hospital, randomly sampled. In our population 10.1% totally ignores the disease; of the remainder, 50% has a good knowledge of signs and symptoms and 37% of RF. To be a woman, (OR: 1.7; 95% CI: 1.2-2.5), the university education (OR: 6.6; 95% CI: 3.0-14.7), the age between 45 and 65 years (OR: 2.5; 95% CI: 1.3-5.0) and to have an afflicted relative (OR: 1.4; 95% CI: 1.001-2.0) are associated with a better stroke knowledge. If symptoms are transient, there is a trend to contact primary physicians (43.5%). Less than a quarter of our population have a good knowledge of the disease. Stroke is considered an emergency unlike TIA. The benefits of public education and the best message for each target population are discussed.
引用
收藏
页码:581 / 586
页数:6
相关论文
共 15 条
[1]
EFFECTS OF PUBLIC AND PROFESSIONAL-EDUCATION ON REDUCING THE DELAY IN PRESENTATION AND REFERRAL OF STROKE PATIENTS [J].
ALBERTS, MJ ;
PERRY, A ;
DAWSON, DV ;
BERTELS, C .
STROKE, 1992, 23 (03) :352-356
[2]
Dornan WA, 1998, STROKE, V29, P288
[3]
FARQUHAR JW, 1997, LANCET, V349, P1192
[4]
Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].
Furlan, A ;
Higashida, R ;
Wechsler, L ;
Gent, M ;
Rowley, H ;
Kase, C ;
Pessin, M ;
Ahuja, A ;
Callahan, F ;
Clark, WM ;
Silver, F ;
Rivera, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011
[5]
KARLINS M, 1970, PERSUASION, P69
[6]
Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience [J].
Katzan, IL ;
Furlan, AJ ;
Lloyd, LE ;
Frank, JI ;
Harper, DL ;
Hinchey, JA ;
Hammel, JP ;
Qu, A ;
Sila, CA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1151-1158
[7]
Patients' awareness of stroke signs, symptoms, and risk factors [J].
Kothari, R ;
Sauerbeck, L ;
Jauch, E ;
Broderick, J ;
Brott, T ;
Khoury, J ;
Liu, TP .
STROKE, 1997, 28 (10) :1871-1875
[8]
TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].
MARLER, JR ;
BROTT, T ;
BRODERICK, J ;
KOTHARI, R ;
ODONOGHUE, M ;
BARSAN, W ;
TOMSICK, T ;
SPILKER, J ;
MILLER, R ;
SAUERBECK, L ;
JARRELL, J ;
KELLY, J ;
PERKINS, T ;
MCDONALD, T ;
RORICK, M ;
HICKEY, C ;
ARMITAGE, J ;
PERRY, C ;
THALINGER, K ;
RHUDE, R ;
SCHILL, J ;
BECKER, PS ;
HEATH, RS ;
ADAMS, D ;
REED, R ;
KLEI, M ;
HUGHES, S ;
ANTHONY, J ;
BAUDENDISTEL, D ;
ZADICOFF, C ;
RYMER, M ;
BETTINGER, I ;
LAUBINGER, P ;
SCHMERLER, M ;
MEIROSE, G ;
LYDEN, P ;
RAPP, K ;
BABCOCK, T ;
DAUM, P ;
PERSONA, D ;
BRODY, M ;
JACKSON, C ;
LEWIS, S ;
LISS, J ;
MAHDAVI, Z ;
ROTHROCK, J ;
TOM, T ;
ZWEIFLER, R ;
DUNFORD, J ;
ZIVIN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587
[9]
MATIASGUIU J, 1993, NEUROEPIDEMIOLOGIA
[10]
Stroke:: A stranger for the population [J].
Montaner, J ;
Mauleón, A ;
Vidal, C ;
Molina, C ;
Alvarez-Sabín, J .
REVISTA DE NEUROLOGIA, 1998, 27 (160) :943-947